BG106952A - Фармацевтичен състав с контролирано освобождаване, съдържащ трамадол хидрохлорид и метод за получаването му - Google Patents

Фармацевтичен състав с контролирано освобождаване, съдържащ трамадол хидрохлорид и метод за получаването му

Info

Publication number
BG106952A
BG106952A BG106952A BG10695202A BG106952A BG 106952 A BG106952 A BG 106952A BG 106952 A BG106952 A BG 106952A BG 10695202 A BG10695202 A BG 10695202A BG 106952 A BG106952 A BG 106952A
Authority
BG
Bulgaria
Prior art keywords
preparation
pharmaceutical composition
controlled release
composition containing
release pharmaceutical
Prior art date
Application number
BG106952A
Other languages
English (en)
Other versions
BG65713B1 (bg
Inventor
Luboslav Razus
Helena Sedlarova
Ivan Varga
Ondrej Gattnar
Marian Zemanek
Original Assignee
Zentiva, A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva, A.S. filed Critical Zentiva, A.S.
Publication of BG106952A publication Critical patent/BG106952A/bg
Publication of BG65713B1 publication Critical patent/BG65713B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Съставът съдържа от 100 до 200 mg от активната съставка трамадол хидрохлорид в смес с микронизираниестери на глицерол с висши мастни киселини, алкални соли на фосфорната киселина, нейонни винилпиролидонови полимери, вещества от групата на солите нависши мастни киселини с алкалоземни метали и силициеви оксиди. Изобретението се отнася и до метод за получаването на този състав.
BG106952A 1999-12-28 2002-07-25 Фармацевтичен състав с контролирано освобождаване, съдържащ трамадол хидрохлорид, и метод за неговото получаване BG65713B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SK1868-99A SK285128B6 (sk) 1999-12-28 1999-12-28 Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy
PCT/SK2000/000027 WO2001047497A2 (en) 1999-12-28 2000-12-20 Controlled release pharmaceutical composition containing tramadol hydrochloride

Publications (2)

Publication Number Publication Date
BG106952A true BG106952A (bg) 2003-03-31
BG65713B1 BG65713B1 (bg) 2009-08-31

Family

ID=20434830

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106952A BG65713B1 (bg) 1999-12-28 2002-07-25 Фармацевтичен състав с контролирано освобождаване, съдържащ трамадол хидрохлорид, и метод за неговото получаване

Country Status (25)

Country Link
US (1) US20030175343A1 (bg)
EP (1) EP1255535B1 (bg)
JP (1) JP2003518486A (bg)
AT (1) ATE324103T1 (bg)
AU (1) AU2421601A (bg)
BG (1) BG65713B1 (bg)
CA (1) CA2397942C (bg)
CY (1) CY1106127T1 (bg)
CZ (1) CZ297394B6 (bg)
DE (1) DE60027601T2 (bg)
DK (1) DK1255535T3 (bg)
EA (1) EA006438B1 (bg)
EE (1) EE05231B1 (bg)
ES (1) ES2266018T3 (bg)
GE (1) GEP20053532B (bg)
HU (1) HUP0203842A3 (bg)
LT (1) LT5033B (bg)
LV (1) LV12917B (bg)
PL (1) PL208096B1 (bg)
PT (1) PT1255535E (bg)
SI (1) SI1255535T1 (bg)
SK (1) SK285128B6 (bg)
TW (1) TWI221419B (bg)
UA (1) UA76411C2 (bg)
WO (1) WO2001047497A2 (bg)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
SK286107B6 (sk) * 2002-04-12 2008-03-05 Zentiva, A. S. Analgeticky účinný perorálny liečivý prípravok s kontrolovaným uvoľňovaním opioidnej účinnej látky a spôsob jeho prípravy
DE10245623A1 (de) * 2002-09-30 2004-04-08 Clariant Gmbh Ester und Partialester aus mehrwertigen Alkoholen
MXPA06000446A (es) * 2003-07-11 2006-04-07 Novartis Ag Composiciones farmaceuticas de dosis oral que comprenden un agente de distribucion en forma micronizada.
NZ573266A (en) * 2006-06-09 2012-01-12 Innophos Inc Calcium fortification substance for clear beverages
US20100143573A1 (en) * 2006-06-09 2010-06-10 John Godber Mineral fortification substance for clear beverages
DE102006044694A1 (de) * 2006-09-22 2008-03-27 Krewel Meuselbach Gmbh Perorale feste Schmerzmittelzubereitung
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
US10835495B2 (en) 2012-11-14 2020-11-17 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
EP0654263B1 (en) 1993-11-23 2002-01-23 Euro-Celtique S.A. Method for preparing a sustained release composition
DE4343993A1 (de) * 1993-12-22 1995-06-29 Stockhausen Chem Fab Gmbh Pfropf-Copolymerisate von ungesättigten Monomeren und Polyhydroxyverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
US5980941A (en) * 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
DE19901683B4 (de) * 1999-01-18 2005-07-21 Grünenthal GmbH Analgetikum mit kontrollierter Wirkstofffreisetzung
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
EE200200368A (et) 2003-10-15
ES2266018T3 (es) 2007-03-01
DE60027601T2 (de) 2007-04-26
CZ20022371A3 (cs) 2002-10-16
SK186899A3 (en) 2001-07-10
US20030175343A1 (en) 2003-09-18
PL357680A1 (en) 2004-07-26
SK285128B6 (sk) 2006-07-07
HUP0203842A2 (hu) 2003-05-28
AU2421601A (en) 2001-07-09
WO2001047497A2 (en) 2001-07-05
DE60027601D1 (de) 2006-06-01
UA76411C2 (en) 2006-08-15
EE05231B1 (et) 2009-12-15
HUP0203842A3 (en) 2004-06-28
WO2001047497A3 (en) 2002-09-12
LT5033B (lt) 2003-07-25
EP1255535B1 (en) 2006-04-26
EA200200720A1 (ru) 2003-02-27
PT1255535E (pt) 2006-09-29
TWI221419B (en) 2004-10-01
EA006438B1 (ru) 2005-12-29
BG65713B1 (bg) 2009-08-31
EP1255535A2 (en) 2002-11-13
CA2397942C (en) 2008-07-15
SI1255535T1 (sl) 2006-10-31
LT2002078A (en) 2003-03-25
CA2397942A1 (en) 2001-07-05
CZ297394B6 (cs) 2006-12-13
ATE324103T1 (de) 2006-05-15
CY1106127T1 (el) 2011-06-08
PL208096B1 (pl) 2011-03-31
GEP20053532B (en) 2005-05-25
LV12917B (en) 2003-02-20
JP2003518486A (ja) 2003-06-10
DK1255535T3 (da) 2006-08-28

Similar Documents

Publication Publication Date Title
WO2001032596A8 (en) Phenoxy carboxylic acid compounds and compositions for delivering active agents
AU679200B2 (en) Effervescent pharmaceutical composition containing ibuprofenand method for preparing same
YU66600A (sh) Farmaceutski preparati koji mogu da budu gelirani
NZ515911A (en) Implantable gel compositions and method of manufacture
YU76503A (sh) Farmaceutski aktivni estri uridina
UA66812C2 (uk) Препаративна форма лікарського засобу із регульованим вивільненням активної речовини
SI1255535T1 (sl) Farmacevtski sestavek s kontroliranim sproscanjem, ki vsebuje tramadol hidroklorid
GB2328872B (en) Method for preparing pharmaceutical formulations
WO2001022969A3 (en) Vasopressin agonist formulation and process
WO2002053097A3 (en) Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
AU2001276410A1 (en) Medicament for oral application, containing aminopropyl phosphonic acid esters as an active ingredient
EP1153611A3 (en) Pharmaceutical composition for the treatment of fibrosis
HUP9902179A2 (hu) Hatóanyagként cisapridot tartalmazó PH-tól független, azonnali hatóanyag felszabadításra alkalmas szilárd gyógyszerkészítmény
BG104733A (bg) Фармацевтичен адхезивен състав за стомаха и/или дуоденума
AU2003219641A1 (en) Analgesical oral composition with controlled release of an opioid
MY152490A (en) New oral formulation